scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1012378283 |
P356 | DOI | 10.1038/NM1720 |
P3181 | OpenCitations bibliographic resource ID | 225205 |
P698 | PubMed publication ID | 18264109 |
P5875 | ResearchGate publication ID | 5588230 |
P50 | author | Wenjun Ouyang | Q37839940 |
Nico Ghilardi | Q47160885 | ||
Dimitry M Danilenko | Q57656690 | ||
Zora Modrusan | Q30582818 | ||
P2093 | author name string | Frederic J de Sauvage | |
Yan Hu | |||
Alexander R Abbas | |||
Yan Zheng | |||
Patricia A Valdez | |||
Qian Gong | |||
Susan M Sa | |||
P2860 | cites work | Mice lacking T and B lymphocytes develop transient colitis and crypt hyperplasia yet suffer impaired bacterial clearance during Citrobacter rodentium infection | Q39654380 |
Cdx1 promotes cellular growth of epithelial intestinal cells through induction of the secretory protein PAP I. | Q40812814 | ||
Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice | Q42620442 | ||
Inhibition of interleukin-22 attenuates bacterial load and organ failure during acute polymicrobial sepsis | Q42799861 | ||
IL-22 participates in an innate anti-HIV-1 host-resistance network through acute-phase protein induction. | Q53581646 | ||
Increased expression of HIP/PAP and regenerating gene III in human inflammatory bowel disease and a murine bacterial reconstitution model. | Q54769090 | ||
Escherichia coli O157:H7 | Q56336651 | ||
The Effects of IL-20 Subfamily Cytokines on Reconstituted Human Epidermis Suggest Potential Roles in Cutaneous Innate Defense and Pathogenic Adaptive Immunity in Psoriasis | Q61356960 | ||
Impaired resistance and enhanced pathology during infection with a noninvasive, attaching-effacing enteric bacterial pathogen, Citrobacter rodentium, in mice lacking IL-12 or IFN-gamma | Q63672301 | ||
Identification of genes involved in mucosal defense and inflammation associated with normal enteric bacteria | Q74227983 | ||
Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts | Q81163296 | ||
IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration | Q82829186 | ||
IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis | Q83163682 | ||
Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F | Q24296262 | ||
Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides | Q24303817 | ||
Symbiotic bacteria direct expression of an intestinal bactericidal lectin | Q24644003 | ||
Production of beta-defensin-2 by human colonic epithelial cells induced by Salmonella enteritidis flagella filament structural protein | Q28208128 | ||
Transforming growth factor-beta induces development of the T(H)17 lineage | Q28237370 | ||
Cutting edge: interleukin 17 signals through a heteromeric receptor complex | Q28247130 | ||
Interleukin-10 and related cytokines and receptors | Q28251518 | ||
IL-22 increases the innate immunity of tissues | Q28276850 | ||
Critical role of T cell-dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen | Q28589275 | ||
IMMUNOLOGY:Enhanced: Defensins and Host Defense | Q29302477 | ||
Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis | Q29620506 | ||
Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury | Q31136783 | ||
Critical role for tumor necrosis factor alpha in controlling the number of lumenal pathogenic bacteria and immunopathology in infectious colitis | Q33552079 | ||
Attaching and effacing locus of a Citrobacter freundii biotype that causes transmissible murine colonic hyperplasia | Q33600087 | ||
Cutting edge: immune cells as sources and targets of the IL-10 family members? | Q34129701 | ||
Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies. | Q34144392 | ||
Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae | Q34450323 | ||
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation | Q34683399 | ||
Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators | Q35219039 | ||
Activation of RegIIIbeta/gamma and interferon gamma expression in the intestinal tract of SCID mice: an innate response to bacterial colonisation of the gut. | Q35597375 | ||
Interleukin-17: a mediator of inflammatory responses. | Q35683883 | ||
Expression patterns of IL-10 ligand and receptor gene families provide leads for biological characterization. | Q35761650 | ||
IL-22, a Th1 cytokine that targets the pancreas and select other peripheral tissues | Q35761673 | ||
Interleukin 22 is a candidate gene for Tmevp3, a locus controlling Theiler's virus-induced neurological diseases | Q35910940 | ||
Immunity, inflammation, and allergy in the gut. | Q36080132 | ||
Animal models of inflammatory bowel disease: lessons from enteric infections | Q36631411 | ||
Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation | Q36732543 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | interleukins | Q194908 |
P304 | page(s) | 282-289 | |
P577 | publication date | 2008-02-10 | |
P1433 | published in | Nature Medicine | Q1633234 |
P1476 | title | Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens | |
P478 | volume | 14 |
Q42930045 | 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Impairs Stable Establishment of Oral Tolerance in Mice |
Q42874171 | A Molecular Link Between Interleukin 22 and Intestinal Mucosal Wound Healing |
Q43905966 | A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells |
Q35061095 | A balanced IL-1β activity is required for host response to Citrobacter rodentium infection |
Q35621970 | A breakthrough in probiotics: Clostridium butyricum regulates gut homeostasis and anti-inflammatory response in inflammatory bowel disease |
Q48231667 | A catch-22: Interleukin-22 and cancer |
Q35824636 | A comprehensive review of the nasal microbiome in chronic rhinosinusitis (CRS). |
Q54212214 | A cytokine network involving IL-36γ, IL-23, and IL-22 promotes antimicrobial defense and recovery from intestinal barrier damage. |
Q28299539 | A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity |
Q90288738 | A lower duodenal immune response is associated with an increase of insulin resistance in patients with morbid obesity |
Q33585268 | A mouse model of HIES reveals pro- and anti-inflammatory functions of STAT3. |
Q36080701 | A novel IL-17 signaling pathway controlling keratinocyte proliferation and tumorigenesis via the TRAF4-ERK5 axis |
Q42604117 | A novel immunoregulatory function for IL-23: Inhibition of IL-12-dependent IFN-γ production |
Q48130689 | A novel, dual cytokine-secretion assay for the purification of human Th22 cells that do not co-produce IL-17A. |
Q37640462 | A role for IL-22 in the relationship between intestinal helminths, gut microbiota and mucosal immunity. |
Q26851559 | A role for Th17 cells in the regulation of tertiary lymphoid follicles |
Q38170180 | A tale of two cytokines: IL-17 and IL-22 in asthma and infection |
Q36309139 | AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch |
Q59136978 | ATF3 Sustains IL-22-Induced STAT3 Phosphorylation to Maintain Mucosal Immunity Through Inhibiting Phosphatases |
Q58700139 | ATG16L1 orchestrates interleukin-22 signaling in the intestinal epithelium via cGAS-STING |
Q54628324 | Absence of IL-23p19 in donor allogeneic cells reduces mortality from acute GVHD. |
Q35115394 | Absence of interleukin 22 affects the oral microbiota and the progression of induced periapical lesions in murine teeth. |
Q39030391 | Absence of intestinal PPARγ aggravates acute infectious colitis in mice through a lipocalin-2-dependent pathway |
Q26765767 | Acinetobacter baumannii Infection and IL-17 Mediated Immunity |
Q37564579 | Acquisition of innate-like microbial reactivity in mucosal tissues during human fetal MAIT-cell development |
Q88779471 | Activating and inhibitory receptors expressed on innate lymphoid cells |
Q92511318 | Activation of Resolution Pathways to Prevent and Fight Chronic Inflammation: Lessons From Asthma and Inflammatory Bowel Disease |
Q51751177 | Activation of Type 3 innate lymphoid cells and interleukin 22 secretion in the lungs during Streptococcus pneumoniae infection. |
Q35208507 | Activation of intestinal epithelial Stat3 orchestrates tissue defense during gastrointestinal infection |
Q36980291 | Activation of the Renin-Angiotensin System Promotes Colitis Development |
Q42938656 | Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells |
Q36494694 | Active vitamin D (1,25-dihydroxyvitamin D3) increases host susceptibility to Citrobacter rodentium by suppressing mucosal Th17 responses |
Q50998497 | Acute infection of mice with Clostridium difficile leads to eIF2α phosphorylation and pro-survival signalling as part of the mucosal inflammatory response. |
Q98178331 | Advances and Challenges in Studying Type III Secretion Effectors of Attaching and Effacing Pathogens |
Q57194204 | AhR modulates the IL-22-producing cell proliferation/recruitment in imiquimod-induced psoriasis mouse model |
Q34064885 | Altering host resistance to infections through microbial transplantation |
Q98159044 | Ambiguous roles and potential therapeutic strategies of innate lymphoid cells in different types of tumor |
Q55208795 | Ambiguous roles of innate lymphoid cells in chronic development of liver diseases. |
Q58557294 | An Interleukin-23-Interleukin-22 Axis Regulates Intestinal Microbial Homeostasis to Protect from Diet-Induced Atherosclerosis |
Q35551320 | An SNP selection strategy identified IL-22 associating with susceptibility to tuberculosis in Chinese |
Q40053514 | An entirely automated method to score DSS-induced colitis in mice by digital image analysis of pathology slides |
Q38233854 | An overview of the role of innate lymphoid cells in gut infections and inflammation |
Q37791260 | Animal models of IBD: linkage to human disease |
Q24642507 | Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity |
Q61652830 | Anti-microbial Functions of Group 3 Innate Lymphoid Cells in Gut-Associated Lymphoid Tissues Are Regulated by G-Protein-Coupled Receptor 183 |
Q33567987 | Antigen-Presenting Human γδ T Cells Promote Intestinal CD4+ T Cell Expression of IL-22 and Mucosal Release of Calprotectin |
Q37845328 | Are NOD2 polymorphisms linked to a specific disease endophenotype of Crohn's disease? |
Q37821982 | Are Th17 cells an appropriate new target in the treatment of rheumatoid arthritis? |
Q34969719 | Aryl hydrocarbon receptor promotes RORγt⁺ group 3 ILCs and controls intestinal immunity and inflammation |
Q26853011 | Aryl hydrocarbon receptor: a molecular link between postnatal lymphoid follicle formation and diet |
Q35746474 | Association of Mucosal Organisms with Patterns of Inflammation in Chronic Rhinosinusitis |
Q34135558 | Averting inflammation by targeting the cytokine environment |
Q64989295 | BVES is required for maintenance of colonic epithelial integrity in experimental colitis by modifying intestinal permeability. |
Q47135898 | Bacillus anthracis lethal toxin negatively modulates ILC3 function through perturbation of IL-23-mediated MAPK signaling. |
Q33609732 | Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection. |
Q40091646 | Bacteroidales recruit IL-6-producing intraepithelial lymphocytes in the colon to promote barrier integrity. |
Q26998388 | Balancing acts: the role of TGF-β in the mucosal immune system |
Q40238781 | Bap180/Baf180 is required to maintain homeostasis of intestinal innate immune response in Drosophila and mice |
Q33759935 | Beyond NK cells: the expanding universe of innate lymphoid cells. |
Q40276600 | Bile Acid Administration Elicits an Intestinal Antimicrobial Program and Reduces the Bacterial Burden in Two Mouse Models of Enteric Infection |
Q38753752 | Biological and pathological activities of interleukin-22. |
Q30385283 | Biology of interleukin-22. |
Q42177330 | Biomarkers of Therapeutic Response in the IL-23 Pathway in Inflammatory Bowel Disease |
Q37275902 | Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease. |
Q37866633 | Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. |
Q26782801 | Breast Milk and Solid Food Shaping Intestinal Immunity |
Q96952258 | Brg1 restrains the pro-inflammatory properties of ILC3s and modulates intestinal immunity |
Q40071271 | Butyrate Supplementation at High Concentrations Alters Enteric Bacterial Communities and Reduces Intestinal Inflammation in Mice Infected with Citrobacter rodentium |
Q37286597 | CCR6 is required for IL-23-induced psoriasis-like inflammation in mice |
Q34813153 | CD4 T cells: fates, functions, and faults |
Q36622318 | CD4(+) T-cell subsets and host defense in the lung |
Q34562235 | CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. |
Q43679940 | CD8+ Sézary syndrome with interleukin-22 production modulated by bacterial sepsis |
Q36499693 | CX(3)CR1(+) macrophages support IL-22 production by innate lymphoid cells during infection with Citrobacter rodentium |
Q36166383 | CXCR2-dependent mucosal neutrophil influx protects against colitis-associated diarrhea caused by an attaching/effacing lesion-forming bacterial pathogen. |
Q36163565 | CXCR6 Expression Is Important for Retention and Circulation of ILC Precursors. |
Q33964256 | CX₃CR1⁺ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. |
Q27335116 | Canine uterine bacterial infection induces upregulation of proteolysis-related genes and downregulation of homeobox and zinc finger factors |
Q88228803 | Canonical Wnt Signaling in CD11c+ APCs Regulates Microbiota-Induced Inflammation and Immune Cell Homeostasis in the Colon |
Q37194665 | Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice |
Q36015747 | Celiac Disease-Related Inflammation Is Marked by Reduction of Nkp44/Nkp46-Double Positive Natural Killer Cells |
Q35360459 | Cellular Plasticity of CD4+ T Cells in the Intestine |
Q47969259 | Changes in protein serum levels during stem cell transplantation. |
Q54394197 | Characterization of gliadin-specific Th17 cells from the mucosa of celiac disease patients. |
Q36923913 | Chlorine gas exposure increases susceptibility to invasive lung fungal infection |
Q49356025 | Chronic Rhinosinusitis with Polyps Is Characterized by Increased Mucosal and Blood Th17 Effector Cytokine Producing Cells. |
Q33642445 | Cigarette smoke-induced oxidative stress suppresses generation of dendritic cell IL-12 and IL-23 through ERK-dependent pathways |
Q91803475 | Citrobacter rodentium Induces Tissue-Resident Memory CD4+ T Cells |
Q50097654 | Citrobacter rodentium Infection Model for the Analysis of Bacterial Pathogenesis and Mucosal Immunology. |
Q90697813 | Citrobacter rodentium induces rapid and unique metabolic and inflammatory responses in mice suffering from severe disease |
Q36126306 | Citrobacter rodentium mouse model of bacterial infection |
Q90197702 | Citrobacter rodentium-host-microbiota interactions: immunity, bioenergetics and metabolism |
Q39371758 | Citrobacter rodentium: a model enteropathogen for understanding the interplay of innate and adaptive components of type 3 immunity |
Q35218043 | Citrobacter rodentium: infection, inflammation and the microbiota |
Q37265849 | Clinical consequences of targeting IL-17 and TH17 in autoimmune and allergic disorders |
Q47596967 | Clinical importance of IL-22 cascade in IBD. |
Q38079585 | Clinical relevance of natural killer cells following hematopoietic stem cell transplantation |
Q28066226 | Close Encounters of Lymphoid Cells and Bacteria |
Q43855252 | Co-expression of S. Typhi GroEL and IL-22 gene augments immune responses against Salmonella infection |
Q27000267 | Collateral damage: microbiota-derived metabolites and immune function in the antibiotic era |
Q43734294 | Colonic microbiota alters host susceptibility to infectious colitis by modulating inflammation, redox status, and ion transporter gene expression |
Q38882799 | Colonization and effector functions of innate lymphoid cells in mucosal tissues |
Q64102152 | Commensal and Pathogenic Bacteria Indirectly Induce IL-22 but Not IFNγ Production From Human Colonic ILC3s via Multiple Mechanisms |
Q54334422 | Commensal and probiotic bacteria influence intestinal barrier function and susceptibility to colitis in Nod1-/-; Nod2-/- mice. |
Q34583618 | Commensal bacteria protect against food allergen sensitization |
Q90638800 | Commensals Suppress Intestinal Epithelial Cell Retinoic Acid Synthesis to Regulate Interleukin-22 Activity and Prevent Microbial Dysbiosis |
Q89171057 | Common ground: shared risk factors for type 1 diabetes and celiac disease |
Q36742533 | Common risk alleles for inflammatory diseases are targets of recent positive selection |
Q33487584 | Community-wide response of the gut microbiota to enteropathogenic Citrobacter rodentium infection revealed by deep sequencing |
Q35165584 | Comparison of a classical Th1 bacteria versus a Th17 bacteria as adjuvant in the induction of experimental autoimmune encephalomyelitis |
Q42500332 | Comparison of interferon-γ-, interleukin (IL)-17- and IL-22-expressing CD4 T cells, IL-22-expressing granulocytes and proinflammatory cytokines during latent and active tuberculosis infection. |
Q34502663 | Complementarity and redundancy of IL-22-producing innate lymphoid cells. |
Q38215842 | Complementary diversification of dendritic cells and innate lymphoid cells. |
Q47947339 | Constitutive induction of intestinal Tc17 cells in the absence of hematopoietic cell-specific MHC class II expression |
Q27009419 | Contextual functions of antigen-presenting cells in the gastrointestinal tract |
Q35928405 | Contrasting Roles of IL-22 and IL-17 in Murine Genital Tract Infection by Neisseria gonorrhoeae. |
Q93161851 | Control and dysregulation of redox signalling in the gastrointestinal tract |
Q37851543 | Control of epithelial cell function by interleukin-22-producing RORγt+ innate lymphoid cells |
Q27013060 | Control of pathogens and pathobionts by the gut microbiota |
Q37716155 | Conventional NK cells can produce IL-22 and promote host defense in Klebsiella pneumoniae pneumonia |
Q40600498 | Critical Role of IL-22/IL22-RA1 Signaling in Pneumococcal Pneumonia |
Q27318086 | Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection |
Q35546730 | Critical roles of chemokine receptor CCR10 in regulating memory IgA responses in intestines |
Q64056525 | Cross-Talk Between Antigen Presenting Cells and T Cells Impacts Intestinal Homeostasis, Bacterial Infections, and Tumorigenesis |
Q39256177 | Cross-talk between RORγt+ innate lymphoid cells and intestinal macrophages induces mucosal IL-22 production in Crohn's disease |
Q35785264 | Cross-talk between type 3 innate lymphoid cells and the gut microbiota in inflammatory bowel disease |
Q90176799 | Crosstalk Between Gut Microbiota and Innate Immunity and Its Implication in Autoimmune Diseases |
Q39078228 | Crosstalk between intestinal epithelial cell and adaptive immune cell in intestinal mucosal immunity. |
Q37083768 | Crystallization and preliminary X-ray diffraction analysis of human IL-22 bound to its soluble decoy receptor IL-22BP. |
Q37326640 | Cytokine mediators of Th17 function |
Q34249937 | Cytokine requirements for the differentiation and expansion of IL-17A- and IL-22-producing human Vgamma2Vdelta2 T cells. |
Q38857894 | Cytokine responses and epithelial function in the intestinal mucosa |
Q37133450 | Cytokine signaling modules in inflammatory responses |
Q33983999 | Cytokine-mediated regulation of antimicrobial proteins |
Q39028574 | Cytokines IL-17 and IL-22 in the host response to infection |
Q37863274 | Cytokines and effector T cell subsets causing autoimmune CNS disease |
Q28080901 | Cytokines, IBD, and colitis-associated cancer |
Q36286343 | Cytotoxic effector functions of T cells are not required for protective immunity against fatal Rickettsia typhi infection in a murine model of infection: Role of TH1 and TH17 cytokines in protection and pathology |
Q47744401 | DCs: a dual bridge to protective immunity |
Q39658184 | DMBT1 is a novel gene induced by IL-22 in ulcerative colitis |
Q36996171 | DOCK2 confers immunity and intestinal colonization resistance to Citrobacter rodentium infection |
Q34055620 | DOCK8 regulates protective immunity by controlling the function and survival of RORγt+ ILCs |
Q27010494 | Death-defining immune responses after apoptosis |
Q26861554 | Deciphering the transcriptional switches of innate lymphoid cell programming: the right factors at the right time |
Q40312759 | Dectin-1-dependent interleukin-22 contributes to early innate lung defense against Aspergillus fumigatus. |
Q54376104 | Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease. |
Q37352441 | Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency |
Q36961744 | Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice |
Q35080739 | Dendritic cell CD83 homotypic interactions regulate inflammation and promote mucosal homeostasis |
Q35190718 | Dendritic cell-epithelial cell crosstalk in the gut. |
Q28071695 | Development and Function of Secondary and Tertiary Lymphoid Organs in the Small Intestine and the Colon |
Q26829933 | Development and survival of Th17 cells within the intestines: the influence of microbiome- and diet-derived signals |
Q33881956 | Development of fatal intestinal inflammation in MyD88 deficient mice co-infected with helminth and bacterial enteropathogens |
Q41927622 | Development, Diversity, and Function of Dendritic Cells in Mouse and Human |
Q38252608 | Development, differentiation, and diversity of innate lymphoid cells |
Q37682642 | Development, regulation and functional capacities of Th17 cells |
Q28573335 | Dexamethasone suppresses interleukin-22 associated with bacterial infection in vitro and in vivo |
Q47175311 | Dietary Copper-Fructose Interactions Alter Gut Microbial Activity in Male Rats. |
Q99604278 | Dietary Fructose Alters the Composition, Localization and Metabolism of Gut Microbiota in Association with Worsening Colitis |
Q36237164 | Dietary vitamin D3 deficiency alters intestinal mucosal defense and increases susceptibility to Citrobacter rodentium-induced colitis |
Q36509083 | Differential Requirements for IL-17A and IL-22 in Cecal versus Colonic Inflammation Induced by Helicobacter hepaticus. |
Q34504910 | Differential capacity of human skin dendritic cells to polarize CD4+ T cells into IL-17, IL-21 and IL-22 producing cells |
Q90092715 | Differential effects of Th17 cytokines during the response of neutrophils to Burkholderia cenocepacia outer membrane protein A |
Q37335567 | Differential induction of antimicrobial REGIII by the intestinal microbiota and Bifidobacterium breve NCC2950. |
Q33535840 | Differentiation, distribution and gammadelta T cell-driven regulation of IL-22-producing T cells in tuberculosis |
Q51770922 | Diseases that may benefit from manipulating the Th17 pathway. |
Q92447462 | Dissecting the Heterogeneity in T-Cell Mediated Inflammation in IBD |
Q27010199 | Diversity of IL-17-producing T lymphocytes |
Q36693141 | Diversity, function, and transcriptional regulation of gut innate lymphocytes |
Q97521540 | Does an Apple a Day Also Keep the Microbes Away? The Interplay Between Diet, Microbiota, and Host Defense Peptides at the Intestinal Mucosal Barrier |
Q57194260 | Dual Role of IL-22 in Allergic Airway Inflammation and its Cross-talk with IL-17A |
Q38940192 | Dynamics of Th17 associating cytokines in Cryptosporidium parvum-infected mice |
Q36297601 | Dysbiosis and the immune system |
Q35332507 | Dysbiosis caused by vitamin D receptor deficiency confers colonization resistance to Citrobacter rodentium through modulation of innate lymphoid cells |
Q28075218 | Dysregulation of Group 3 Innate Lymphoid Cells in the Pathogenesis of Inflammatory Bowel Disease |
Q90701275 | Dysregulation of Intestinal Microbiota Elicited by Food Allergy Induces IgA-Mediated Oral Dysbiosis |
Q33728489 | Early production of IL-22 but not IL-17 by peripheral blood mononuclear cells exposed to live Borrelia burgdorferi: the role of monocytes and interleukin-1. |
Q36516823 | Ecto-nucleoside triphosphate diphosphohydrolase 7 controls Th17 cell responses through regulation of luminal ATP in the small intestine |
Q40194679 | Effect of High Dietary Manganese on the Immune Responses of Broilers Following Oral Salmonella typhimurium Inoculation |
Q55176161 | Effector T Helper Cell Subsets in Inflammatory Bowel Diseases. |
Q27024742 | Effector and memory T cell responses to commensal bacteria |
Q90220060 | Elevated Expression of Serum Amyloid A 3 Protects Colon Epithelium Against Acute Injury Through TLR2-Dependent Induction of Neutrophil IL-22 Expression in a Mouse Model of Colitis |
Q30431530 | Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma |
Q37360656 | Emergence of the Th17 pathway and its role in host defense. |
Q37346684 | Emerging concepts and future challenges in innate lymphoid cell biology |
Q37028324 | Emerging roles for antigen presentation in establishing host-microbiome symbiosis |
Q35133818 | Endogenous IL-22 plays a dual role in arthritis: regulation of established arthritis via IFN-γ responses |
Q27307208 | Enteric infection with Citrobacter rodentium induces coagulative liver necrosis and hepatic inflammation prior to peak infection and colonic disease |
Q42233193 | Enteric mucosa integrity in the presence of a preserved innate interleukin 22 compartment in HIV type 1-treated individuals |
Q60584774 | Enterobacteria and host resistance to infection |
Q35558450 | Epigenetic modifications of the immune system in health and disease |
Q42130297 | Epithelial Cell Inflammasomes in Intestinal Immunity and Inflammation |
Q90290748 | Epithelial Cells as a Transmitter of Signals From Commensal Bacteria and Host Immune Cells |
Q40216623 | Epithelial Histone Deacetylase 3 Instructs Intestinal Immunity by Coordinating Local Lymphocyte Activation. |
Q34308070 | Epithelial IL-22RA1-mediated fucosylation promotes intestinal colonization resistance to an opportunistic pathogen |
Q30853216 | Epithelial IL-23R Signaling Licenses Protective IL-22 Responses in Intestinal Inflammation |
Q38985455 | Epithelial glycosylation in gut homeostasis and inflammation |
Q33598575 | Epithelial p38alpha controls immune cell recruitment in the colonic mucosa. |
Q34931410 | Epithelial phosphatidylinositol-3-kinase signaling is required for β-catenin activation and host defense against Citrobacter rodentium infection. |
Q36080691 | Epithelial-intrinsic IKKα expression regulates group 3 innate lymphoid cell responses and antibacterial immunity. |
Q34998232 | Epstein Barr virus-induced 3 (EBI3) together with IL-12 negatively regulates T helper 17-mediated immunity to Listeria monocytogenes infection |
Q93103591 | EspF is crucial for Citrobacter rodentium-induced tight junction disruption and lethality in immunocompromised animals |
Q50027164 | Essential immunologic orchestrators of intestinal homeostasis. |
Q33874975 | Establishment and function of tissue-resident innate lymphoid cells in the skin |
Q35866812 | Expression and Significance of the HIP/PAP and RegIIIγ Antimicrobial Peptides during Mammalian Urinary Tract Infection |
Q47160095 | Expression of REG family genes in human inflammatory bowel diseases and its regulation |
Q36819589 | Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis |
Q84567439 | Expression, purification and characterization of recombinant human interleukin-22 in Pichia pastoris |
Q38986519 | Feedback control of AHR signalling regulates intestinal immunity |
Q89681192 | Feeding-dependent VIP neuron-ILC3 circuit regulates the intestinal barrier |
Q49587798 | Fiber-Mediated Nourishment of Gut Microbiota Protects against Diet-Induced Obesity by Restoring IL-22-Mediated Colonic Health. |
Q92803637 | Flagellin hypervariable region determines symbiotic properties of commensal Escherichia coli strains |
Q37611966 | Flagellin-Mediated Protection against Intestinal Yersinia pseudotuberculosis Infection Does Not Require Interleukin-22 |
Q38142595 | From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa |
Q37374943 | From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited |
Q39034173 | Functional and phenotypic heterogeneity of group 3 innate lymphoid cells |
Q37850400 | Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease |
Q64080792 | Functions of Macrophages in the Maintenance of Intestinal Homeostasis |
Q38985483 | Functions of Murine Dendritic Cells |
Q35854795 | Functions of innate immune cells and commensal bacteria in gut homeostasis |
Q46267304 | Fungi in Gastrointestinal Tracts of Human and Mice: from Community to Functions |
Q50060109 | G.I. pros: Antimicrobial defense in the gastrointestinal tract. |
Q34058590 | GM-CSF-facilitated dendritic cell recruitment and survival govern the intestinal mucosal response to a mouse enteric bacterial pathogen. |
Q59333340 | GVHD: biology matters |
Q90029154 | GVHD: biology matters |
Q33877159 | Gamma interferon produced by antigen-specific CD4+ T cells regulates the mucosal immune responses to Citrobacter rodentium infection |
Q36419359 | Ganglioside-binding specificities of E. coli enterotoxin LT-IIc: Importance of long-chain fatty acyl ceramide |
Q35876185 | Gastric LTi cells promote lymphoid follicle formation but are limited by IRAK-M and do not alter microbial growth |
Q37576715 | Gata3 drives development of RORγt+ group 3 innate lymphoid cells. |
Q58478071 | Gene expression of selected signature cytokines of T cell subsets in duodenal tissues of dogs with and without inflammatory bowel disease |
Q37619851 | Genetic deficiencies of innate immune signalling in human infectious disease |
Q46444584 | Genetic origins of hyper-IgE syndrome |
Q34454590 | Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma |
Q98894968 | Gingival crevicular fluid levels of Interleukin-22 (IL-22) and human β Defensin-2 (hBD-2) in periodontal health and disease : A correlative study |
Q89449439 | Glucocorticoids Inhibit Group 3 Innate Lymphocyte IL-22 Production |
Q37067094 | Gluten-sensitive enteropathy coincides with decreased capability of intestinal T cells to secrete IL-17 and IL-22 in a macaque model for celiac disease |
Q27318038 | Goblet Cell Derived RELM-β Recruits CD4+ T Cells during Infectious Colitis to Promote Protective Intestinal Epithelial Cell Proliferation |
Q87994387 | Gpr109a Limits Microbiota-Induced IL-23 Production To Constrain ILC3-Mediated Colonic Inflammation |
Q64071688 | Group 3 ILCs: Peacekeepers or Troublemakers? What's Your Gut Telling You?! |
Q47138366 | Group 3 Innate Lymphoid Cells: Communications Hubs of the Intestinal Immune System |
Q28081074 | Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice |
Q37448373 | Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora. |
Q38602944 | Group 3 innate lymphoid cells: regulating host-commensal bacteria interactions in inflammation and cancer |
Q34978181 | Guanylate cyclase C limits systemic dissemination of a murine enteric pathogen. |
Q49938175 | Gut Epithelial Vitamin D Receptor Regulates Microbiota-Dependent Mucosal Inflammation by Suppressing Intestinal Epithelial Cell Apoptosis. |
Q90310328 | Gut microbiota and cardiovascular disease: opportunities and challenges |
Q38776970 | Gut microbiota-mediated protection against diarrheal infections |
Q57098637 | Gut microbiota-mediated protection against influenza virus subtype H9N2 in chickens is associated with modulation of the innate responses |
Q40278970 | Gut symbiotic microbes imprint intestinal immune cells with the innate receptor SLAMF4 which contributes to gut immune protection against enteric pathogens |
Q50422322 | HIC1 links retinoic acid signalling to group 3 innate lymphoid cell-dependent regulation of intestinal immunity and homeostasis. |
Q26998418 | HVEM is a TNF Receptor with Multiple Regulatory Roles in the Mucosal Immune System |
Q28590892 | HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria |
Q36677090 | HVEM: An unusual TNF receptor family member important for mucosal innate immune responses to microbes |
Q37152701 | Hallmarks of Tissue-Resident Lymphocytes |
Q38535119 | Harnessing the Therapeutic Potential of Th17 Cells |
Q36443057 | Have we made progress in the treatment of GVHD? |
Q37987526 | Healing of intestinal inflammation by IL-22. |
Q40274577 | Helminth-induced alterations of the gut microbiota exacerbate bacterial colitis |
Q27021587 | Hematopoietic progenitor cells are innate Th2 cytokine-producing cells |
Q37381928 | Hidden talents of natural killers: NK cells in innate and adaptive immunity |
Q37044955 | High Fat Diets Induce Colonic Epithelial Cell Stress and Inflammation that is Reversed by IL-22 |
Q38924841 | High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission |
Q33736978 | High systemic levels of interleukin-10, interleukin-22 and C-reactive protein in Indian patients are associated with low in vitro replication of HIV-1 subtype C viruses |
Q36923759 | Homeostatic PPARα Signaling Limits Inflammatory Responses to Commensal Microbiota in the Intestine. |
Q34279908 | Homeostatic regulation of Salmonella-induced mucosal inflammation and injury by IL-23 |
Q82268841 | Host immune response to antibiotic perturbation of the microbiota |
Q39077398 | Host-Microbiota Interactions Shape Local and Systemic Inflammatory Diseases |
Q38167443 | Host-microbial interactions in patients with chronic rhinosinusitis |
Q36295242 | Host-microbiota interactions in inflammatory bowel disease |
Q64067984 | Human Gut-Associated Natural Killer Cells in Health and Disease |
Q39345202 | Human IL-22 binding protein isoforms act as a rheostat for IL-22 signaling. |
Q84933191 | Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161 |
Q41813956 | Human Langerhans cells control Th cells via programmed death-ligand 1 in response to bacterial stimuli and nickel-induced contact allergy |
Q33564666 | Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production |
Q42915172 | Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells |
Q40718573 | Humoral Immunity in the Gut Selectively Targets Phenotypically Virulent Attaching-and-Effacing Bacteria for Intraluminal Elimination. |
Q27322468 | Hypercytotoxicity and rapid loss of NKp44+ innate lymphoid cells during acute SIV infection |
Q33849531 | Hypothermia Promotes Interleukin-22 Expression and Fine-Tunes Its Biological Activity. |
Q92642952 | IFN-I and IL-22 mediate protective effects of intestinal viral infection |
Q38983262 | IL-1 signaling modulates activation of STAT transcription factors to antagonize retinoic acid signaling and control the TH17 cell-iTreg cell balance |
Q37974986 | IL-10 and IL-10 receptor defects in humans. |
Q24658015 | IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani |
Q21296685 | IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain-Barré syndrome |
Q39179415 | IL-17 and IL-22 in immunity: Driving protection and pathology |
Q34193357 | IL-17 in protective immunity to intracellular pathogens |
Q33815790 | IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice |
Q38138107 | IL-17 producing T cells in celiac disease: angels or devils? |
Q39314770 | IL-17+ γδ T cells as kick-starters of inflammation. |
Q36142154 | IL-17-induced Act1-mediated signaling is critical for cuprizone-induced demyelination |
Q36985422 | IL-17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIV-infected macaques |
Q38040743 | IL-17-producing γδ T cells and innate lymphoid cells |
Q46089935 | IL-17/Th17 in anti-fungal immunity: what's new? |
Q38129869 | IL-17A and Th17 cells in lung inflammation: an update on the role of Th17 cell differentiation and IL-17R signaling in host defense against infection. |
Q33810455 | IL-17A produced by gammadelta T cells plays a critical role in innate immunity against listeria monocytogenes infection in the liver |
Q35874754 | IL-17A produced by αβ T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction |
Q47603312 | IL-17A-Induced PLET1 Expression Contributes to Tissue Repair and Colon Tumorigenesis. |
Q39394243 | IL-17A-mediated neutrophil recruitment limits expansion of segmented filamentous bacteria. |
Q37398319 | IL-17F: regulation, signaling and function in inflammation |
Q90711448 | IL-17R-EGFR axis links wound healing to tumorigenesis in Lrig1+ stem cells |
Q28506505 | IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tail |
Q24629783 | IL-17RC: a partner in IL-17 signaling and beyond |
Q39459097 | IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens |
Q35920946 | IL-17a and IL-22 Induce Expression of Antimicrobials in Gastrointestinal Epithelial Cells and May Contribute to Epithelial Cell Defense against Helicobacter pylori |
Q92249406 | IL-21 Controls ILC3 Cytokine Production and Promotes a Protective Phenotype in a Mouse Model of Colitis |
Q34148906 | IL-21 induces IL-22 production in CD4+ T cells. |
Q37693697 | IL-22 Controls Iron-Dependent Nutritional Immunity Against Systemic Bacterial Infections |
Q36540978 | IL-22 Defect During Streptococcus pneumoniae Infection Triggers Exacerbation of Chronic Obstructive Pulmonary Disease |
Q27301071 | IL-22 Protects against Tissue Damage during Cutaneous Leishmaniasis |
Q27315163 | IL-22 Restrains Tapeworm-Mediated Protection against Experimental Colitis via Regulation of IL-25 Expression |
Q38928473 | IL-22 Up-Regulates β-Defensin-2 Expression in Human Alveolar Epithelium via STAT3 but Not NF-κB Signaling Pathway |
Q41616535 | IL-22 and IL-22 binding protein (IL-22BP) regulate fibrosis and cirrhosis in hepatitis C virus and schistosome infections. |
Q37328260 | IL-22 and inflammation: leukin' through a glass onion |
Q46485022 | IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium |
Q30539616 | IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic. |
Q54217819 | IL-22 deficiency increases CD4 T cell responses to mucosal immunization. |
Q51054891 | IL-22 defines a novel immune pathway of antifungal resistance. |
Q34364633 | IL-22 fate reporter reveals origin and control of IL-22 production in homeostasis and infection |
Q42875392 | IL-22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection |
Q45963493 | IL-22 in mucosal immunity. |
Q37228800 | IL-22 in the endometriotic milieu promotes the proliferation of endometrial stromal cells via stimulating the secretion of CCL2 and IL-8 |
Q38093227 | IL-22 in tissue-protective therapy |
Q47948534 | IL-22 induces Reg3γ and inhibits allergic inflammation in house dust mite-induced asthma models. |
Q34608524 | IL-22 is mainly produced by IFNγ-secreting cells but is dispensable for host protection against Mycobacterium tuberculosis infection |
Q57194265 | IL-22 is produced by γC-independent CD25+ CCR6+ innate murine spleen cells upon inflammatory stimuli and contributes to LPS-induced lethality |
Q41147927 | IL-22 is rapidly induced by Pathogen Recognition Receptors Stimulation in Bone-Marrow-derived Dendritic Cells in the Absence of IL-23. |
Q36909129 | IL-22 levels are associated with Trichomonas vaginalis infection in the lower genital tract. |
Q35018086 | IL-22 mediates goblet cell hyperplasia and worm expulsion in intestinal helminth infection |
Q33604771 | IL-22 negatively regulates Helicobacter pylori-induced CCL20 expression in gastric epithelial cells |
Q33828316 | IL-22 production is regulated by IL-23 during Listeria monocytogenes infection but is not required for bacterial clearance or tissue protection |
Q38842154 | IL-22 promotes the proliferation of cancer cells in smoking colorectal cancer patients |
Q100635623 | IL-22 receptor signaling in Paneth cells is critical for their maturation, microbiota colonization, Th17-related immune responses, and anti-Salmonella immunity |
Q34406318 | IL-22 signaling contributes to West Nile encephalitis pathogenesis |
Q38711326 | IL-22 suppresses the infection of porcine enteric coronaviruses and rotavirus by activating STAT3 signal pathway |
Q33655332 | IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L |
Q38081171 | IL-22, not simply a Th17 cytokine |
Q35552028 | IL-22-STAT3 pathway plays a key role in the maintenance of ileal homeostasis in mice lacking secreted mucus barrier. |
Q40688722 | IL-22-induced antimicrobial peptides are key determinants of mucosal vaccine-induced protection against H. pylori in mice. |
Q35399287 | IL-22-induced regulatory CD11b+ APCs suppress experimental autoimmune uveitis |
Q34733135 | IL-22-producing CD4+ cells are depleted in actively inflamed colitis tissue |
Q37068500 | IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis. |
Q38079587 | IL-22: An Evolutionary Missing-Link Authenticating the Role of the Immune System in Tissue Regeneration |
Q37393834 | IL-22: a critical mediator in mucosal host defense |
Q44944229 | IL-22BP dictates characteristics of Peyer's patch follicle-associated epithelium for antigen uptake |
Q53360318 | IL-22BP is produced by eosinophils in human gut and blocks IL-22 protective actions during colitis. |
Q36261228 | IL-22R Ligands IL-20, IL-22, and IL-24 Promote Wound Healing in Diabetic db/db Mice |
Q40171045 | IL-22 Upregulates Epithelial Claudin-2 to Drive Diarrhea and Enteric Pathogen Clearance |
Q37349727 | IL-23 and Th17 cytokines in intestinal homeostasis |
Q37275024 | IL-23 induced in keratinocytes by endogenous TLR4 ligands polarizes dendritic cells to drive IL-22 responses to skin immunization |
Q37366047 | IL-23 induces IL-22 and IL-17 production in response to Chlamydia muridarum genital tract infection, but the absence of these cytokines does not influence disease pathogenesis |
Q33693895 | IL-23 receptor regulates unconventional IL-17-producing T cells that control bacterial infections |
Q50904070 | IL-23 restoration of Th17 effector function is independent of IL-6 and TGF-β in a mouse model of alcohol and burn injury. |
Q41437315 | IL-23-mediated mononuclear phagocyte crosstalk protects mice from Citrobacter rodentium-induced colon immunopathology. |
Q92760637 | IL-23-producing IL-10Rα-deficient gut macrophages elicit an IL-22-driven proinflammatory epithelial cell response |
Q38711141 | IL-24 Promotes Pseudomonas aeruginosa Keratitis in C57BL/6 Mouse Corneas |
Q34501413 | IL-27 promotes T cell-dependent colitis through multiple mechanisms |
Q29614594 | IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer |
Q37994026 | IL-7: the global builder of the innate lymphoid network and beyond, one niche at a time |
Q90419317 | ILC2 Activation by Protozoan Commensal Microbes |
Q91808408 | ILC3s integrate glycolysis and mitochondrial production of reactive oxygen species to fulfill activation demands |
Q95660451 | Identification of Reference Genes in Chicken Intraepithelial Lymphocyte Natural Killer Cells Infected with Very-virulent Infectious Bursal Disease Virus |
Q50041515 | Identification of an innate T helper type 17 response to intestinal bacterial pathogens. |
Q35177247 | Identity, regulation and in vivo function of gut NKp46+RORγt+ and NKp46+RORγt- lymphoid cells |
Q64118813 | IgG and Fcγ Receptors in Intestinal Immunity and Inflammation |
Q34100501 | Immune adaptations that maintain homeostasis with the intestinal microbiota |
Q34143465 | Immune and genetic gardening of the intestinal microbiome. |
Q38558749 | Immune deficiency vs. immune excess in inflammatory bowel diseases-STAT3 as a rheo-STAT of intestinal homeostasis |
Q38182446 | Immune-epithelial crosstalk at the intestinal surface |
Q37385720 | Immunoexpression of interleukin-22 and interleukin-23 in oral and cutaneous lichen planus lesions: a preliminary study |
Q38359982 | Immunomodulating properties of protein hydrolysates for application in cow's milk allergy. |
Q37991394 | Immunomodulation for gastrointestinal infections. |
Q102141646 | Immunopathobiology and therapeutic targets related to cytokines in liver diseases |
Q38407555 | Immunopathogenesis of Myocarditis: The Interplay Between Cardiac Fibroblast Cells, Dendritic Cells, Macrophages and CD4+ T Cells |
Q38004933 | Immunoregulation by the gut microbiota |
Q39092013 | Impact of Childhood Malnutrition on Host Defense and Infection |
Q96428639 | Impact of birth weight and neonatal nutritional interventions with micronutrients and bovine colostrum on the development of piglet immune response during the peri-weaning period |
Q36602307 | In utero exposure to arsenic alters lung development and genes related to immune and mucociliary function in mice |
Q38086226 | In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections |
Q37776837 | Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines? |
Q37336750 | Increased Escherichia coli-induced interleukin-23 production by CD16+ monocytes correlates with systemic immune activation in untreated HIV-1-infected individuals. |
Q36328418 | Increased Expression of DUOX2 Is an Epithelial Response to Mucosal Dysbiosis Required for Immune Homeostasis in Mouse Intestine |
Q34634513 | Increased expression of IL-22 is associated with disease activity in Behcet's disease |
Q36531638 | Increased expressions of IL-22 and Th22 cells in the coxsackievirus B3-Induced mice acute viral myocarditis |
Q46136325 | Increased intratumoral IL-22-producing CD4(+) T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival |
Q34279235 | Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors |
Q91889502 | Induction of IL-22 protein and IL-22-producing cells in rainbow trout Oncorhynchus mykiss |
Q37574096 | Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection |
Q28131638 | Induction of intestinal Th17 cells by segmented filamentous bacteria |
Q37688392 | Infection and apoptosis as a combined inflammatory trigger |
Q35644145 | Inflammation and repeated infections in CGD: two sides of a coin |
Q36556660 | Inflammatory Responses to Salmonella Infections Are Serotype-Specific |
Q41990376 | Inflammatory bactericidal lectin RegIIIβ: Friend or Foe for the host? |
Q37454505 | Inflammatory bowel disease and mutations affecting the interleukin-10 receptor |
Q37945495 | Inflammatory bowel disease: is it a primary immunodeficiency? |
Q36396866 | Inflammatory monocyte recruitment is regulated by interleukin-23 during systemic bacterial infection |
Q47844444 | Influence of hypoxia-inducible factor 1α on dendritic cell differentiation and migration |
Q38539813 | Influence of nutrient-derived metabolites on lymphocyte immunity |
Q42604162 | Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin |
Q34764015 | Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice |
Q37604453 | Influenza A virus exacerbates Staphylococcus aureus pneumonia in mice by attenuating antimicrobial peptide production |
Q40151457 | Initial Gut Microbial Composition as a Key Factor Driving Host Response to Antibiotic Treatment, as Exemplified by the Presence or Absence of Commensal Escherichia coli |
Q33608575 | Innate IL-17-producing cells: the sentinels of the immune system |
Q35957398 | Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile Infection |
Q36828457 | Innate Lymphocyte/Ly6C(hi) Monocyte Crosstalk Promotes Klebsiella Pneumoniae Clearance |
Q47162429 | Innate Lymphoid Cells (ILCs) as Mediators of Inflammation, Release of Cytokines and Lytic Molecules |
Q49920496 | Innate Lymphoid Cells (ILCs): Cytokine Hubs Regulating Immunity and Tissue Homeostasis. |
Q40019073 | Innate Lymphoid Cells Are Depleted Irreversibly during Acute HIV-1 Infection in the Absence of Viral Suppression. |
Q35611711 | Innate Lymphoid Cells Control Early Colonization Resistance against Intestinal Pathogens through ID2-Dependent Regulation of the Microbiota. |
Q89495092 | Innate Lymphoid Cells in Colorectal Cancers: A Double-Edged Sword |
Q47554808 | Innate Lymphoid Cells in HIV/SIV Infections |
Q42683314 | Innate Lymphoid Cells in Intestinal Inflammation |
Q64255314 | Innate Lymphoid Cells in Mucosal Immunity |
Q64230647 | Innate Lymphoid Cells: A Link between the Nervous System and Microbiota in Intestinal Networks |
Q53402699 | Innate Lymphoid Cells: A Promising New Regulator in Fibrotic Diseases. |
Q64084898 | Innate Lymphoid Cells: Expression of PD-1 and Other Checkpoints in Normal and Pathological Conditions |
Q28510473 | Innate Stat3-mediated induction of the antimicrobial protein Reg3γ is required for host defense against MRSA pneumonia |
Q37974695 | Innate host responses to enteric bacterial pathogens: a balancing act between resistance and tolerance. |
Q46099764 | Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation. |
Q36019373 | Innate immune response to Salmonella typhimurium, a model enteric pathogen |
Q27002611 | Innate immune signaling in defense against intestinal microbes |
Q38702344 | Innate immunity restricts Citrobacter rodentium A/E pathogenesis initiation to an early window of opportunity. |
Q38872152 | Innate lymphoid cell function in the context of adaptive immunity |
Q91725321 | Innate lymphoid cell type 3-derived interleukin-22 boosts lipocalin-2 production in intestinal epithelial cells via synergy between STAT3 and NF-κB |
Q38763067 | Innate lymphoid cells as novel regulators of obesity and its-associated metabolic dysfunction |
Q38872144 | Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. |
Q94591730 | Innate lymphoid cells control signaling circuits to regulate tissue-specific immunity |
Q87718734 | Innate lymphoid cells in defense, immunopathology and immunotherapy |
Q38605374 | Innate lymphoid cells in intestinal immunity and inflammation |
Q38165175 | Innate lymphoid cells in the defense against infections |
Q36908615 | Innate lymphoid cells in the initiation, regulation and resolution of inflammation |
Q34279451 | Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. |
Q36822687 | Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model |
Q38071916 | Innate lymphoid cells--how did we miss them? |
Q92560950 | Innate lymphoid cells: A potential link between microbiota and immune responses against cancer |
Q36645149 | Innate lymphoid cells: balancing immunity, inflammation, and tissue repair in the intestine. |
Q38077406 | Innate lymphoid cells: from border protection to the initiation of inflammatory diseases |
Q42747718 | Innate-like function of memory Th17 cells for enhancing endotoxin-induced acute lung inflammation through IL-22 |
Q33956973 | Insights into IBD Pathogenesis |
Q37953824 | Insights into inflammatory bowel disease using Toxoplasma gondii as an infectious trigger |
Q64102240 | Interactions Between the Gut Microbiota and the Host Innate Immune Response Against Pathogens |
Q34397537 | Interactions between the intestinal microbiota and innate lymphoid cells. |
Q89108679 | Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier |
Q27655546 | Interferon- Is Functionally an Interferon but Structurally Related to the Interleukin-10 Family |
Q36108222 | Interferon-λ and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection |
Q26801049 | Interferon-λ: Immune Functions at Barrier Surfaces and Beyond |
Q33590409 | Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. |
Q39314776 | Interleukin 17 is a chief orchestrator of immunity |
Q33708468 | Interleukin 22 attenuated angiotensin II induced acute lung injury through inhibiting the apoptosis of pulmonary microvascular endothelial cells |
Q37520186 | Interleukin 22 inhibits intracellular growth of Mycobacterium tuberculosis by enhancing calgranulin A expression. |
Q46186059 | Interleukin 22 polymorphisms and papillary thyroid cancer |
Q35784100 | Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense. |
Q37680986 | Interleukin and interleukin receptor diversity: role of alternative splicing |
Q35833796 | Interleukin-1 (IL-1) signaling in intestinal stromal cells controls KC/ CXCL1 secretion, which correlates with recruitment of IL-22- secreting neutrophils at early stages of Citrobacter rodentium infection |
Q38034469 | Interleukin-10 and interleukin-10-receptor defects in inflammatory bowel disease |
Q54375943 | Interleukin-13-mediated paneth cell degranulation and antimicrobial peptide release. |
Q37728837 | Interleukin-17 and its expanding biological functions. |
Q37735334 | Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease |
Q37552021 | Interleukin-17 and systemic lupus erythematosus: current concepts |
Q50073548 | Interleukin-17 family cytokines in protective immunity against infections: role of hematopoietic cell-derived and non-hematopoietic cell-derived interleukin-17s. |
Q51358143 | Interleukin-17 in skin: psoriasis and yonder. |
Q35009321 | Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis |
Q36879626 | Interleukin-17 promotes formation and growth of prostate adenocarcinoma in mouse models |
Q39229039 | Interleukin-17A is required to suppress invasion of Salmonella enterica serovar Typhimurium to enteric mucosa |
Q38885474 | Interleukin-17B Antagonizes Interleukin-25-Mediated Mucosal Inflammation. |
Q39610932 | Interleukin-21 induces the differentiation of human Tc22 cells via phosphorylation of signal transducers and activators of transcription |
Q92881803 | Interleukin-22 (IL-22) Binding Protein Constrains IL-22 Activity, Host Defense, and Oxidative Phosphorylation Genes during Pneumococcal Pneumonia |
Q33964145 | Interleukin-22 (IL-22) production by pulmonary Natural Killer cells and the potential role of IL-22 during primary influenza virus infection |
Q96680272 | Interleukin-22 Inhibits Respiratory Syncytial Virus Production by Blocking Virus-Mediated Subversion of Cellular Autophagy |
Q26770224 | Interleukin-22 Signaling in the Regulation of Intestinal Health and Disease |
Q46323162 | Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes |
Q24658609 | Interleukin-22 ameliorates acute severe pancreatitis-associated lung injury in mice |
Q41696303 | Interleukin-22 and CD160 play additive roles in the host mucosal response to Clostridium difficile infection in mice |
Q43102028 | Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid |
Q40332859 | Interleukin-22 drives nitric oxide-dependent DNA damage and dysplasia in a murine model of colitis-associated cancer |
Q52691346 | Interleukin-22 immunotherapy during severe influenza enhances lung tissue integrity and reduces secondary bacterial systemic invasion. |
Q26752528 | Interleukin-22 in Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation |
Q27687335 | Interleukin-22 in kidney injury and regeneration |
Q96305053 | Interleukin-22 in urinary tract disease - new experimental directions |
Q35841871 | Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages |
Q40059573 | Interleukin-22 level is negatively correlated with neutrophil recruitment in the lungs in a Pseudomonas aeruginosa pneumonia model. |
Q31119980 | Interleukin-22 mediates early host defense against Rhizomucor pusilluscan pathogens |
Q36478883 | Interleukin-22 modulates gut epithelial and immune barrier functions following acute alcohol exposure and burn injury |
Q91618743 | Interleukin-22 orchestrates a pathological endoplasmic reticulum stress response transcriptional programme in colonic epithelial cells |
Q34411311 | Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study |
Q46118254 | Interleukin-22 produced by alveolar macrophages during activation of the innate immune response |
Q35095074 | Interleukin-22 promotes T helper 1 (Th1)/Th17 immunity in chlamydial lung infection |
Q36483525 | Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration |
Q57050132 | Interleukin-22 promotes phagolysosomal fusion to induce protection against Typhimurium in human epithelial cells |
Q64994747 | Interleukin-22 receptor 1 is expressed in multinucleated giant cells: A study on intestinal tuberculosis and Crohn's disease. |
Q36911822 | Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection. |
Q36745327 | Interleukin-22 reduces the severity of collagen-induced arthritis in association with increased levels of interleukin-10. |
Q53139446 | Interleukin-22 regulates antimicrobial peptide expression and keratinocyte differentiation to control Staphylococcus aureus colonization of the nasal mucosa. |
Q34453038 | Interleukin-22 regulates the complement system to promote resistance against pathobionts after pathogen-induced intestinal damage. |
Q39320252 | Interleukin-22-Induced Antimicrobial Phospholipase A2 Group IIA Mediates Protective Innate Immunity of Nonhematopoietic Cells against Listeria monocytogenes. |
Q88574244 | Interleukin-22-deficiency and microbiota contribute to the exacerbation of Toxoplasma gondii-induced intestinal inflammation |
Q89748728 | Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota |
Q80830002 | Interleukin-22: a sheep in wolf's clothing |
Q35530956 | Interleukin-22: immunobiology and pathology |
Q40444654 | Interleukin-23 (IL-23), independent of IL-17 and IL-22, drives neutrophil recruitment and innate inflammation during Clostridium difficile colitis in mice |
Q37883457 | Interleukin-23 and T helper 17-type responses in intestinal inflammation: from cytokines to T-cell plasticity |
Q38444161 | Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells. |
Q37033085 | Interleukin-23 orchestrates mucosal responses to Salmonella enterica serotype Typhimurium in the intestine |
Q30276969 | Interleukin-25 Mediated Induction of Angiogenin-4 Is Interleukin-13 Dependent |
Q64262246 | Interleukin‑22 regulates the homeostasis of the intestinal epithelium during inflammation |
Q36255322 | Intestinal Epithelial Cell Tyrosine Kinase 2 Transduces IL-22 Signals To Protect from Acute Colitis |
Q64086064 | Intestinal Epithelial Cells and the Microbiome Undergo Swift Reprogramming at the Inception of Colonic Citrobacter rodentium Infection |
Q36820029 | Intestinal Expression of Genes Encoding Inflammatory Mediators and Gelatinases During Arcobacter Butzleri Infection of Gnotobiotic Il-10 Deficient Mice |
Q61814283 | Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHD |
Q35717842 | Intestinal Microbiota of Mice Influences Resistance to Staphylococcus aureus Pneumonia. |
Q38971101 | Intestinal commensal bacteria mediate lung mucosal immunity and promote resistance of newborn mice to infection |
Q90058368 | Intestinal epithelial cells: at the interface of the microbiota and mucosal immunity |
Q35655273 | Intestinal fucose as a mediator of host-microbe symbiosis. |
Q35073346 | Intestinal intraepithelial lymphocyte-enterocyte crosstalk regulates production of bactericidal angiogenin 4 by Paneth cells upon microbial challenge |
Q37194987 | Intestinal lamina propria dendritic cells maintain T cell homeostasis but do not affect commensalism. |
Q35953647 | Intestinal macrophages arising from CCR2(+) monocytes control pathogen infection by activating innate lymphoid cells. |
Q35144584 | Intestinal microbiota and its effects on the immune system |
Q37845442 | Intestinal microbiota, evolution of the immune system and the bad reputation of pro-inflammatory immunity |
Q37194943 | Intestinal monocytes and macrophages are required for T cell polarization in response to Citrobacter rodentium |
Q47108861 | Investigation of the relationship between the Th17/IL-23 pathway and innate-adaptive immune system in TNBS-induced colitis in rats |
Q28270049 | Involvement of the IL-22/REG Ialpha axis in ulcerative colitis |
Q36285745 | JAK Kinases in Health and Disease: An Update |
Q91723380 | JunB plays a crucial role in development of regulatory T cells by promoting IL-2 signaling |
Q98222237 | Keeping time in group 3 innate lymphoid cells |
Q57099305 | LIGHT-HVEM Signaling in Innate Lymphoid Cell Subsets Protects Against Enteric Bacterial Infection |
Q40952787 | Lack of the programmed death-1 receptor renders host susceptible to enteric microbial infection through impairing the production of the mucosal natural killer cell effector molecules. |
Q47403907 | Lactobacillus plantarum Enhanced IL-22 Production in Natural Killer (NK) Cells That Protect the Integrity of Intestinal Epithelial Cell Barrier Damaged by Enterotoxigenic Escherichia coli |
Q37216050 | Lactobacillus reuteri and Staphylococcus aureus differentially influence the generation of monocyte-derived dendritic cells and subsequent autologous T cell responses |
Q39265291 | Late developmental plasticity in the T helper 17 lineage |
Q30422264 | Leptin and mucosal immunity |
Q37612560 | Life in the inflamed intestine, Salmonella style |
Q38040744 | Life, death, and miracles: Th17 cells in the intestine |
Q57520258 | Lineage Relationship Analysis of RORγt+Innate Lymphoid Cells |
Q42371536 | Lipocalin 2 regulates intestine bacterial survival by interplaying with siderophore in a weaned piglet model of Escherichia coli infection |
Q37401782 | Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine |
Q26752371 | Local and Long-Distance Calling: Conversations between the Gut Microbiota and Intra- and Extra-Gastrointestinal Tract Infections |
Q43601759 | Long-term selenium deficiency increases the pathogenicity of a Citrobacter rodentium infection in mice |
Q27316093 | Loss of Function of Intestinal IL-17 and IL-22 Producing Cells Contributes to Inflammation and Viral Persistence in SIV-Infected Rhesus Macaques |
Q48231615 | Loss of disease tolerance during Citrobacter rodentium infection is associated with impaired epithelial differentiation and hyperactivation of T cell responses |
Q37783745 | Lymphoid tissue inducer cells and the evolution of CD4 dependent high-affinity antibody responses. |
Q37594571 | Lymphoid tissue inducer cells: bridges between the ancient innate and the modern adaptive immune systems |
Q37977138 | Lymphoid tissue inducer cells: innate cells critical for CD4+ T cell memory responses? |
Q83409279 | Lymphotoxin and the amazing technicolor circus of intestinal homeostasis |
Q33883606 | Lymphotoxin beta receptor signaling in intestinal epithelial cells orchestrates innate immune responses against mucosal bacterial infection |
Q35189278 | Lymphotoxin beta receptor signaling limits mucosal damage through driving IL-23 production by epithelial cells. |
Q36031510 | Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge. |
Q37722321 | Lymphotoxin organizes contributions to host defense and metabolic illness from innate lymphoid cells |
Q34295896 | Lymphotoxin regulates commensal responses to enable diet-induced obesity |
Q34308847 | Lymphotoxin, NF-ĸB, and cancer: the dark side of cytokines |
Q58478653 | Lymphotoxin-β receptor-independent development of intestinal IL-22-producing NKp46+ innate lymphoid cells |
Q34991544 | Lyn activity protects mice from DSS colitis and regulates the production of IL-22 from innate lymphoid cells. |
Q90975684 | Lypd8 inhibits attachment of pathogenic bacteria to colonic epithelia |
Q58769609 | M cell-dependent antigen uptake on follicle-associated epithelium for mucosal immune surveillance |
Q64240832 | Macrophage β2-Integrins Regulate IL-22 by ILC3s and Protect from Lethal Citrobacter rodentium-Induced Colitis |
Q38869770 | Mechanisms and consequences of intestinal dysbiosis. |
Q35096758 | Mechanisms controlling Th17 cytokine expression and host defense |
Q26766654 | Mechanisms of interleukin-22's beneficial effects in acute pancreatitis |
Q35763089 | Mechanisms of rapid induction of interleukin-22 in activated T cells and its modulation by cyclosporin a. |
Q34796036 | Melatonin and ulcerative colitis: evidence, biological mechanisms, and future research |
Q36650805 | Membrane-bound IL-22 after de novo production in tuberculosis and anti-Mycobacterium tuberculosis effector function of IL-22+ CD4+ T cells |
Q28245271 | Memory IL-22-producing CD4+ T cells specific for Candida albicans are present in humans |
Q34973693 | Memory/effector (CD45RB(lo)) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology |
Q92157568 | Metabolism at the centre of the host-microbe relationship |
Q34288647 | Microbial-immune cross-talk and regulation of the immune system |
Q91891671 | Microbiota-induced tissue signals regulate ILC3-mediated antigen presentation |
Q34324937 | Microbiota-mediated colonization resistance against intestinal pathogens |
Q35541605 | Microbiota-mediated inflammation and antimicrobial defense in the intestine |
Q89637281 | Microfold cell-dependent antigen transport alleviates infectious colitis by inducing antigen-specific cellular immunity |
Q37727840 | Microparticles released by Listeria monocytogenes-infected macrophages are required for dendritic cell-elicited protective immunity |
Q37546964 | Model of Host-Pathogen Interaction Dynamics Links In Vivo Optical Imaging and Immune Responses |
Q51770929 | Modulation of Th17 development and function by activation of the aryl hydrocarbon receptor--the role of endogenous ligands. |
Q35235355 | Modulation of immune development and function by intestinal microbiota. |
Q49710668 | Molecular characteristics of rhesus macaque interleukin-22: cloning, in vitro expression and biological activities. |
Q37273205 | Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome |
Q38144077 | Molecular mechanisms and cell targets of Th17 cells in the gastrointestinal tract: an innate sense of adaptivity. |
Q91307598 | Molecular signature of interleukin-22 in colon carcinoma cells and organoid models |
Q37862089 | Morphology of segmented filamentous bacteria and their patterns of contact with the follicle-associated epithelium of the mouse terminal ileum: implications for the relationship with the immune system |
Q33582232 | Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa |
Q49551961 | Mucocutaneous IL-17 immunity in mice and humans: host defense vs. excessive inflammation. |
Q26741117 | Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel Disease |
Q38742453 | Mucosal immunity to pathogenic intestinal bacteria. |
Q36957775 | Mucosal immunology of HIV infection |
Q38177725 | Mucosal innate immune cells regulate both gut homeostasis and intestinal inflammation |
Q27334516 | Multifunctional double-negative T cells in sooty mangabeys mediate T-helper functions irrespective of SIV infection |
Q37718355 | Multiple hats for natural killers |
Q33728144 | Multivariate modeling identifies neutrophil- and Th17-related factors as differential serum biomarkers of chronic murine colitis |
Q38137645 | Murine models of Candida gastrointestinal colonization and dissemination |
Q33693973 | MyD88 signaling in dendritic cells and the intestinal epithelium controls immunity against intestinal infection with C. rodentium. |
Q35799053 | Myeloid STAT3 promotes formation of colitis-associated colorectal cancer in mice |
Q91704520 | NIK signaling axis regulates dendritic cell function in intestinal immunity and homeostasis |
Q98177647 | NK Cell Development in Times of Innate Lymphoid Cell Diversity |
Q26744632 | NK Cells and Other Innate Lymphoid Cells in Hematopoietic Stem Cell Transplantation |
Q58606356 | NK Cells in HIV-1 Infection: From Basic Science to Vaccine Strategies |
Q44764762 | NK cells exacerbate the pathology of influenza virus infection in mice |
Q36083904 | NK1.1+ cells and IL-22 regulate vaccine-induced protective immunity against challenge with Mycobacterium tuberculosis |
Q53652932 | NK22 Cells in the Uterine Mid-Secretory Endometrium and Peripheral Blood of Women with Recurrent Pregnancy Loss and Unexplained Infertility. |
Q39606134 | NLRC4 expression in intestinal epithelial cells mediates protection against an enteric pathogen. |
Q36932453 | Nasal vaccination stimulates CD8(+) T cells for potent protection against mucosal Brucella melitensis challenge |
Q28251675 | Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles |
Q37568931 | Natural killer (NK) and NK-like cells at mucosal epithelia: Mediators of anti-microbial defense and maintenance of tissue integrity |
Q36558792 | Natural killer cells protect against mucosal and systemic infection with the enteric pathogen Citrobacter rodentium |
Q92318936 | Necroptosis of Intestinal Epithelial Cells Induces Type 3 Innate Lymphoid Cell-Dependent Lethal Ileitis |
Q40243203 | Neonatal acquisition of Clostridia species protects against colonization by bacterial pathogens. |
Q57181221 | Neuroendocrine regulation of innate lymphoid cells |
Q37706595 | Neutrophils recruited by IL-22 in peripheral tissues function as TRAIL-dependent antiviral effectors against MCMV. |
Q55334211 | New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma. |
Q34994147 | New activation modus of STAT3: a tyrosine-less region of the interleukin-22 receptor recruits STAT3 by interacting with its coiled-coil domain |
Q38075724 | New friendships and old feuds: relationships between innate lymphoid cells and microbial communities |
Q34175958 | New insights into T cell biology and T cell-directed therapy for autoimmunity, inflammation, and immunosuppression |
Q37779724 | New insights into the development of lymphoid tissues |
Q36557738 | NleB, a bacterial effector with glycosyltransferase activity, targets GAPDH function to inhibit NF-κB activation |
Q40397061 | Nlrp3 activation in the intestinal epithelium protects against a mucosal pathogen |
Q35478936 | No vacancy: how beneficial microbes cooperate with immunity to provide colonization resistance to pathogens |
Q34645833 | Nod1 and Nod2 signaling does not alter the composition of intestinal bacterial communities at homeostasis |
Q35365098 | Non-therapeutic administration of a model antimicrobial growth promoter modulates intestinal immune responses |
Q59134894 | Nonclinical safety assessment of a human interleukin-22FC IG fusion protein demonstrates in vitro to in vivo and cross-species translatability |
Q40094981 | Nongenetically modified Lactococcus lactis-adjuvanted vaccination enhanced innate immunity against Helicobacter pylori. |
Q33778205 | Notch signaling drives IL-22 secretion in CD4+ T cells by stimulating the aryl hydrocarbon receptor. |
Q28509751 | Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens |
Q84781198 | Novel Tools for Modulating Immune Responses in the Host—Polysaccharides from the Capsule of Commensal Bacteria |
Q38936163 | Novel role for IL-22 in protection during chronic Mycobacterium tuberculosis HN878 infection. |
Q46089932 | Novel therapeutic targets along the Th17 pathway |
Q37948124 | OX40 and CD30 signals in CD4(+) T-cell effector and memory function: a distinct role for lymphoid tissue inducer cells in maintaining CD4(+) T-cell memory but not effector function |
Q38899075 | Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice |
Q46413941 | Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in mice. |
Q54218424 | Orchestration of intestinal homeostasis and tolerance by group 3 innate lymphoid cells. |
Q59806954 | Origin, Differentiation, and Function of Intestinal Macrophages |
Q39250716 | Origins and evolution of innate lymphoid cells: Wardens of barrier immunity |
Q91312483 | PAD4-dependent NETs generation are indispensable for intestinal clearance of Citrobacter rodentium |
Q38550186 | Parasites: what are they good for? |
Q24597173 | Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A |
Q33899365 | Perfluorooctane sulfonate affects intestinal immunity against bacterial infection |
Q57792326 | Peyer's patch myeloid cells infection by signals through gp38 stromal cells and locks intestinal villus invasion |
Q42256398 | Phenotypic characterization of very early-onset IBD due to mutations in the IL10, IL10 receptor alpha or beta gene: a survey of the Genius Working Group |
Q38381708 | Plasma-derived proteomic biomarkers in human leukocyte antigen-haploidentical or human leukocyte antigen-matched bone marrow transplantation using post-transplantation cyclophosphamide |
Q64063162 | Plasmacytoid Dendritic Cells Provide Protection Against Bacterial-Induced Colitis |
Q100738502 | Plasmacytoid dendritic cells regulate host immune response to Citrobacter rodentium -induced colitis in colon-draining lymph nodes |
Q39055343 | Postbiotic Modulation of Retinoic Acid Imprinted Mucosal-like Dendritic Cells by Probiotic Lactobacillus reuteri 17938 In Vitro. |
Q38377895 | Potential of the Cnidium monnieri fruits as an immune enhancer in Escherichia coli infection model |
Q40477171 | Potential role of Th17 cells in the pathogenesis of type 2 autoimmune pancreatitis. |
Q42284439 | Praziquantel treatment after Schistosoma japonicum infection maintains hepatic insulin sensitivity and improves glucose metabolism in mice. |
Q37630095 | Precarious balance: Th17 cells in host defense. |
Q35563366 | Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis |
Q89685652 | Presence of Inflammatory Group I and III Innate Lymphoid Cells in the Colon of SIV-infected Rhesus Macaques |
Q41999154 | Pro-Inflammatory Signaling by IL-10 and IL-22: Bad Habit Stirred Up by Interferons? |
Q37174121 | Protective and destructive innate immune responses to enteropathogenic Escherichia coli and related A/E pathogens |
Q26825858 | Protective and pathological properties of IL-22 in liver disease: implications for viral hepatitis |
Q39704573 | Protective properties of inhaled IL-22 in a model of ventilator-induced lung injury. |
Q40506767 | Protective role of IL-22 against Schistosoma mansoni soluble egg antigen-induced granuloma in Vitro. |
Q38734006 | Protective role of Th17 cells in pulmonary infection |
Q41892852 | Protective role of commensals against Clostridium difficile infection via an IL-1β-mediated positive-feedback loop |
Q60241575 | Provocative exhibits at the Seventeen Gallery |
Q40477924 | Pseudomonas aeruginosa proteolytically alters the interleukin 22-dependent lung mucosal defense. |
Q37018586 | Pulmonary Th17 Antifungal Immunity Is Regulated by the Gut Microbiome |
Q84007863 | Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma |
Q34295528 | Quantitative RT-PCR profiling of the rabbit immune response: assessment of acute Shigella flexneri infection |
Q35980031 | R-Spondins Are Expressed by the Intestinal Stroma and are Differentially Regulated during Citrobacter rodentium- and DSS-Induced Colitis in Mice |
Q34441341 | RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells |
Q93380331 | RORγt Represses IL-10 Production in Th17 Cells To Maintain Their Pathogenicity in Inducing Intestinal Inflammation |
Q46167903 | RORγt+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota |
Q37987044 | RORγt-dependent IL-17A-producing cells in the pathogenesis of intestinal inflammation |
Q89305209 | Randomized Phase I Healthy Volunteer Study of UTTR1147A (IL-22Fc): A Potential Therapy for Epithelial Injury |
Q36818027 | Re(de)fining the dendritic cell lineage. |
Q37851777 | Recent advances in IL-22 biology. |
Q39215821 | Recent advances in gut immunology. |
Q58050148 | Recipient single nucleotide polymorphisms in Paneth cell antimicrobial peptide genes and acute graft-versus-host disease: analysis of BMT CTN-0201 and -0901 samples |
Q41688465 | Reciprocal Inflammatory Signaling Between Intestinal Epithelial Cells and Adipocytes in the Absence of Immune Cells. |
Q38205440 | Recognition strategies of group 3 innate lymphoid cells |
Q58756600 | Reduced monocyte and macrophage TNFSF15/TL1A expression is associated with susceptibility to inflammatory bowel disease |
Q35205539 | Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections |
Q91879977 | Reg3 Proteins as Gut Hormones? |
Q35623673 | Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease |
Q37348457 | Regulation and function of proinflammatory TH17 cells |
Q38105858 | Regulation of innate and adaptive immunity by Notch |
Q35028444 | Regulation of innate and adaptive immunity by the commensal microbiota |
Q54346247 | Regulation of the development of acute hepatitis by IL-23 through IL-22 and IL-17 production. |
Q34081385 | Regulation of the gut microbiota by the mucosal immune system in mice |
Q42223231 | Regulatory T cells promote a protective Th17-associated immune response to intestinal bacterial infection with C. rodentium |
Q35899475 | Reparative inflammation takes charge of tissue regeneration |
Q41970839 | Retinoic acid expression associates with enhanced IL-22 production by γδ T cells and innate lymphoid cells and attenuation of intestinal inflammation. |
Q28280687 | Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis |
Q30409278 | Role of class 1 serine protease autotransporter in the pathogenesis of Citrobacter rodentium colitis |
Q27001687 | Role of group 3 innate lymphoid cells in antibody production |
Q42150907 | Role of innate lymphocytes in infection and inflammation |
Q34456769 | Role of interleukin-22 in inflammatory bowel disease |
Q37263002 | Role of mucosal dendritic cells in inflammatory bowel disease |
Q38016151 | Role of the Aryl Hydrocarbon Receptor in Controlling Maintenance and Functional Programs of RORγt(+) Innate Lymphoid Cells and Intraepithelial Lymphocytes |
Q35448732 | Role of the commensal microbiota in normal and pathogenic host immune responses |
Q35052712 | Role of the enteric microbiota in intestinal homeostasis and inflammation |
Q34036490 | Role of the gut microbiota in immunity and inflammatory disease |
Q41863661 | Roles of interleukin-17 in an experimental Legionella pneumophila pneumonia model |
Q30235535 | Roles of the intestinal microbiota in pathogen protection. |
Q37926818 | Rorγt+ innate lymphoid cells in intestinal homeostasis and immunity |
Q58746167 | Runx3 Mediates Resistance to Intracellular Bacterial Infection by Promoting IL12 Signaling in Group 1 ILC and NCR+ILC3 |
Q58760715 | Ruxolitinib inhibits cyclosporine-induced proliferation of cutaneous squamous cell carcinoma |
Q34236471 | SEF/IL-17R (SEFIR) is not enough: an extended SEFIR domain is required for il-17RA-mediated signal transduction |
Q36462335 | SIV replication in the infected rhesus macaque is limited by the size of the preexisting TH17 cell compartment |
Q39145689 | STAT3 activation in infection and infection-associated cancer |
Q41953828 | STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing |
Q26747404 | STAT3, a Key Parameter of Cytokine-Driven Tissue Protection during Sterile Inflammation - the Case of Experimental Acetaminophen (Paracetamol)-Induced Liver Damage |
Q35589806 | STAT3-Activating Cytokines: A Therapeutic Opportunity for Inflammatory Bowel Disease? |
Q84993431 | Securing the border: lymphotoxin, IL-23 and IL-22 keep out the bad guys and 'fatten' the homeland |
Q58705877 | Segmented Filamentous Bacteria - Metabolism Meets Immunity |
Q24620794 | Segmented filamentous bacteria take the stage |
Q35133030 | Segmented filamentous bacteria: commensal microbes with potential effects on research |
Q43279110 | Selected commensal-related bacteria and Toll-like receptor 3 agonist combinatorial codes synergistically induce interleukin-12 production by dendritic cells to trigger a T helper type 1 polarizing programme. |
Q55058453 | Serum regenerating islet-derived 3-alpha is a biomarker of mucosal enteropathies. |
Q47795865 | Short-chain arabinoxylans prepared from enzymatically treated wheat grain exert prebiotic effects during the broiler starter period. |
Q35301398 | Signaling through IL-17C/IL-17RE is dispensable for immunity to systemic, oral and cutaneous candidiasis |
Q37040753 | Signaling via the IL-20 receptor inhibits cutaneous production of IL-1β and IL-17A to promote infection with methicillin-resistant Staphylococcus aureus |
Q93183027 | Single-cell transcriptional analysis reveals ILC-like cells in zebrafish |
Q24648636 | Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine |
Q46194895 | Spotlight on IL-22-producing NK cell receptor-expressing mucosal lymphocytes. |
Q40385188 | Steroid Receptor Coactivator 3 Contributes to Host Defense against Enteric Bacteria by Recruiting Neutrophils via Upregulation of CXCL2 Expression. |
Q34595847 | Strain-dependent cellular immune responses in cattle following Escherichia coli O157:H7 colonization |
Q37590390 | Streptococcus pneumoniae-induced pneumonia and Citrobacter rodentium-induced gut infection differentially alter vitamin A concentrations in the lung and liver of mice |
Q24650068 | Structural basis of receptor sharing by interleukin 17 cytokines |
Q24648045 | Structure and signalling in the IL-17 receptor family |
Q24656543 | Structure of IL-22 bound to its high-affinity IL-22R1 chain |
Q23909610 | Subchronic exposures to fungal bioaerosols promotes allergic pulmonary inflammation in naive mice |
Q40181883 | Supplementation of Low- and High-fat Diets with Fermentable Fiber Exacerbates Severity of DSS-induced Acute Colitis |
Q37633430 | Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease |
Q37669790 | T helper 17 cells: discovery, function, and physiological trigger |
Q35108903 | T helper cell subsets specific for Pseudomonas aeruginosa in healthy individuals and patients with cystic fibrosis |
Q38134677 | T helper cells plasticity in inflammation. |
Q33723154 | T-cell based immunotherapy in experimental autoimmune encephalomyelitis and multiple sclerosis |
Q39950912 | TGF-beta promotes Th17 cell development through inhibition of SOCS3. |
Q95831791 | TGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancer |
Q28276449 | TH17 cells in development: an updated view of their molecular identity and genetic programming |
Q64111557 | TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity |
Q37190661 | TLR-7 activation enhances IL-22-mediated colonization resistance against vancomycin-resistant enterococcus. |
Q34694834 | TLR5 signaling stimulates the innate production of IL-17 and IL-22 by CD3(neg)CD127+ immune cells in spleen and mucosa |
Q92688232 | TREM-1-dependent M1 macrophage polarization restores intestinal epithelium damaged by DSS-induced colitis by activating IL-22-producing innate lymphoid cells |
Q91863389 | TRIM30 modulates Interleukin-22-regulated papillary thyroid Cancer cell migration and invasion by targeting Sox17 for K48-linked Polyubiquitination |
Q35105613 | Tailored immune responses: novel effector helper T cell subsets in protective immunity |
Q45944049 | Targeting IL-10 Family Cytokines for the Treatment of Human Diseases. |
Q38584529 | Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases |
Q38172801 | Targeting interleukins for the treatment of inflammatory bowel disease-what lies beyond anti-TNF therapy? |
Q38548095 | Targeting the gastrointestinal tract to develop novel therapies for HIV. |
Q47591857 | Temporal expression of interleukin-22, interleukin-22 receptor 1 and interleukin-22-binding protein during experimental periodontitis in rats. |
Q34038557 | Th1 and Th17 cells: adversaries and collaborators |
Q34432491 | Th17 Cells Coordinate with Th22 Cells in Maintaining Homeostasis of Intestinal Tissues and both are Depleted in SIV-Infected Macaques |
Q92708713 | Th17 Cells in Helicobacter pylori Infection: a Dichotomy of Help and Harm |
Q37408959 | Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis. |
Q37106755 | Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis |
Q33611067 | Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa |
Q34242697 | Th17 cells mediate clade-specific, serotype-independent mucosal immunity |
Q36188911 | Th17 cells: critical mediators of host responses to burn injury and sepsis |
Q37576442 | Th17 cytokines and host-pathogen interactions at the mucosa: dichotomies of help and harm |
Q33743570 | Th17 cytokines and the gut mucosal barrier |
Q33792227 | Th17 cytokines and vaccine-induced immunity |
Q38138195 | Th17 cytokines in inflammatory bowel diseases: discerning the good from the bad. |
Q33943805 | Th17 cytokines in mucosal immunity and inflammation |
Q38086713 | Th17 lymphocytes in respiratory syncytial virus infection. |
Q38068964 | Th22 and related cytokines in inflammatory and autoimmune diseases |
Q42148408 | Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria |
Q37224613 | Th22 cells control colon tumorigenesis through STAT3 and Polycomb Repression complex 2 signaling |
Q37559676 | The AIM2 inflammasome is a central regulator of intestinal homeostasis through the IL-18/IL-22/STAT3 pathway |
Q58478613 | The Citrobacter rodentium type III secretion system effector EspO affects mucosal damage repair and antimicrobial responses |
Q37215886 | The Current STATus of lymphocyte signaling: new roles for old players. |
Q42512933 | The Development of Steady-State Activation Hubs between Adult LTi ILC3s and Primed Macrophages in Small Intestine. |
Q39388328 | The Enteric Network: Interactions between the Immune and Nervous Systems of the Gut. |
Q37697039 | The IL-17 family cytokines in immunity and disease. |
Q47980800 | The IL-20 cytokine subfamily: bad guys in host defense? |
Q28252101 | The IL-20 subfamily of cytokines--from host defence to tissue homeostasis |
Q37989164 | The IL-23/IL-17 pathway in inflammatory bowel disease |
Q37067927 | The IL-23/IL-22/IL-18 axis in murine Campylobacter jejuni infection |
Q50045033 | The IL20 Genetic Polymorphism Is Associated with Altered Clinical Outcome in Septic Shock. |
Q55399321 | The Interleukin-20 Cytokines in Intestinal Diseases. |
Q38362640 | The Jekyll and Hyde story of IL17-Producing γδT Cells |
Q53720556 | The Mouse Model of Infection with Citrobacter rodentium. |
Q40852964 | The N-glycan on Asn54 affects the atypical N-glycan composition of plant-produced interleukin-22, but does not influence its activity |
Q49223149 | The Resistance to Plague Infection among Meriones persicus from Endemic and Non-endemic Regions in Iran: The Role of Gut Microbiota. |
Q36947949 | The Role of IL-22 in Viral Infections: Paradigms and Paradoxes |
Q91807678 | The Role of Immune Cells and Cytokines in Intestinal Wound Healing |
Q90706788 | The Role of Innate Leukocytes during Influenza Virus Infection |
Q52721472 | The Role of Intestinal C-type Regenerating Islet Derived-3 Lectins for Nonalcoholic Steatohepatitis. |
Q47868098 | The Stimulation of Macrophages with TLR Ligands Supports Increased IL-19 Expression in Inflammatory Bowel Disease Patients and in Colitis Models. |
Q36713721 | The Th17 family: flexibility follows function. |
Q37662888 | The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin |
Q88954027 | The Tumor Necrosis Factor Superfamily Member RANKL Suppresses Effector Cytokine Production in Group 3 Innate Lymphoid Cells |
Q35592370 | The alteration and clinical significance of Th22/Th17/Th1 cells in patients with chronic myeloid leukemia |
Q38008353 | The ambiguity in immunology |
Q34906387 | The anaphase-promoting complex protein 5 (AnapC5) associates with A20 and inhibits IL-17-mediated signal transduction |
Q28507522 | The antimicrobial protein REG3A regulates keratinocyte proliferation and differentiation after skin injury |
Q38137012 | The aryl hydrocarbon receptor in innate T cell immunity |
Q35713322 | The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells |
Q35167005 | The basic leucine zipper transcription factor NFIL3 directs the development of a common innate lymphoid cell precursor |
Q40526547 | The battlefield in the war against attaching-and-effacing bacterial pathogens: Monocytes, macrophages and dendritic cells in action |
Q24614431 | The biological functions of T helper 17 cell effector cytokines in inflammation |
Q38319907 | The biology of innate lymphoid cells |
Q34052242 | The blessings and curses of intestinal inflammation |
Q36027809 | The cell surface receptor Slamf6 modulates innate immune responses during Citrobacter rodentium-induced colitis |
Q27690244 | The crystal structure of zebrafish IL-22 reveals an evolutionary, conserved structure highly similar to that of human IL-22 |
Q37660167 | The cytokine IL-22 promotes pathogen colonization by suppressing related commensal bacteria. |
Q92610628 | The development of colitis in Il10-/- mice is dependent on IL-22 |
Q39337496 | The dichotomous nature of T helper 17 cells |
Q56607716 | The dual nature of TH17 cells: shifting the focus to function |
Q34152180 | The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. |
Q47606845 | The expressions and roles of different forms of IL-22 in Mycobacterium tuberculosis infection. |
Q28286102 | The gut microbiota--masters of host development and physiology |
Q34451272 | The impact of intestinal inflammation on the nutritional environment of the gut microbiota |
Q38293766 | The innate immune system and inflammatory bowel disease. |
Q24594675 | The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases |
Q26745703 | The interplay between the microbiome and the adaptive immune response in cancer development |
Q21195858 | The involvement of interleukin-22 in the expression of pancreatic beta cell regenerative Reg genes |
Q36069070 | The microbiome and innate immunity |
Q35065019 | The microbiome and regulation of mucosal immunity |
Q35181992 | The microbiota and helminths: sharing the same niche in the human host |
Q92229836 | The neuropeptide VIP confers anticipatory mucosal immunity by regulating ILC3 activity |
Q41948431 | The other T helper cells in asthma pathogenesis |
Q34740127 | The pathogenicity of an enteric Citrobacter rodentium Infection is enhanced by deficiencies in the antioxidants selenium and vitamin E. |
Q41993807 | The polysaccharide capsule of Campylobacter jejuni modulates the host immune response |
Q35475800 | The rest of the story: the microbiome and gastrointestinal infections |
Q35423526 | The role of Gr-1(+) cells and tumour necrosis factor-α signalling during Clostridium difficile colitis in mice |
Q54224246 | The role of IL-22 in the resolution of sterile and nonsterile inflammation. |
Q34151076 | The role of Th17 cytokines in primary mucosal immunity |
Q41958263 | The role of aryl hydrocarbon receptor in interleukin-23-dependent restoration of interleukin-22 following ethanol exposure and burn injury |
Q34437865 | The role of commensal bacteria in the regulation of sensitization to food allergens |
Q38184626 | The role of innate and lymphoid IL-22-producing cells in the immunopathology of primary Sjögren's syndrome. |
Q35740637 | The role of innate immunity in the host defense against intestinal bacterial pathogens |
Q48146269 | The role of innate lymphoid cells in health and disease |
Q89665184 | The role of innate lymphoid cells in response to microbes at mucosal surfaces |
Q34126426 | The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease |
Q26750673 | The roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunity |
Q89282567 | The roles for innate lymphoid cells in the human immune system |
Q37995658 | The roles of cells and cytokines in the pathogenesis of psoriasis |
Q39744085 | The single IgG IL-1-related receptor controls TLR responses in differentiated human intestinal epithelial cells |
Q36211058 | The sphingosine-1-phosphate analogue FTY720 impairs mucosal immunity and clearance of the enteric pathogen Citrobacter rodentium. |
Q33360030 | The synovio-entheseal complex in enthesoarthritis |
Q24563655 | The transcription factor T-bet is essential for the development of NKp46+ innate lymphocytes via the Notch pathway |
Q37830196 | The unexpected link between infection-induced apoptosis and a TH17 immune response. |
Q38478216 | The unusual suspects--innate lymphoid cells as novel therapeutic targets in IBD. |
Q37973651 | The yin and yang of immunomodulatory biologics: assessing the delicate balance between benefit and risk |
Q41812432 | The β-glucan receptor dectin-1 promotes lung immunopathology during fungal allergy via IL-22. |
Q36631313 | Therapeutic Role of Interleukin 22 in Experimental Intra-abdominal Klebsiella pneumoniae Infection in Mice. |
Q38174792 | Therapeutic opportunities of the IL-22-IL-22R1 system |
Q90601512 | Therapeutic targets and emerging treatment options in gastrointestinal acute graft-versus-host disease |
Q57181204 | Thinking differently about ILCs-Not just tissue resident and not just the same as CD4 T-cell effectors |
Q38801112 | Though Active on RINm5F Insulinoma Cells and Cultured Pancreatic Islets, Recombinant IL-22 Fails to Modulate Cytotoxicity and Disease in a Protocol of Streptozotocin-Induced Experimental Diabetes |
Q35947385 | Tir Triggers Expression of CXCL1 in Enterocytes and Neutrophil Recruitment during Citrobacter rodentium Infection |
Q57300016 | Tissue-Resident Lymphocytes Across Innate and Adaptive Lineages |
Q92572255 | Tissue-resident cytotoxic innate lymphoid cells in tumor immunosurveillance |
Q38089253 | Tissue-specific effector functions of innate lymphoid cells. |
Q37733573 | Toll-like receptor 4-induced IL-22 accelerates kidney regeneration. |
Q34740026 | Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis. |
Q38650821 | Tpl2 promotes innate cell recruitment and effector T cell differentiation to limit Citrobacter rodentium burden and dissemination |
Q40050850 | Transcript profiling of the immunological interactions between Actinobacillus pleuropneumoniae serotype 7 and the host by dual RNA-seq. |
Q48107813 | Transcription Factor HIF-1α Controls Expression of the Cytokine IL-22 in CD4 T Cells. |
Q46052625 | Transcription factor c-Maf mediates the TGF-β-dependent suppression of IL-22 production in T(H)17 cells. |
Q38192561 | Transcription factors controlling development and function of innate lymphoid cells |
Q37468541 | Transcriptional Control of Dendritic Cell Development. |
Q27005868 | Transcriptional control of innate lymphoid cells |
Q37425866 | Transcriptional regulatory networks in Th17 cell differentiation |
Q101038726 | Transcriptome analysis of chicken intraepithelial lymphocyte natural killer cells infected with very virulent infectious bursal disease virus |
Q34984567 | Transcriptome profiling reveals Th17-like immune responses induced in zebrafish bath-vaccinated with a live attenuated Vibrio anguillarum |
Q39316961 | Transforming growth factor β: a master regulator of the gut microbiota and immune cell interactions. |
Q28829881 | Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells |
Q37511583 | Transition metal ions at the crossroads of mucosal immunity and microbial pathogenesis |
Q26824855 | Treg cells: a potential regulator for IL-22 expression? |
Q34450251 | Triple Cytokine FluoroSpot Analysis of Human Antigen-Specific IFN-γ, IL-17A and IL-22 Responses |
Q36184781 | Tristetraprolin regulation of interleukin-22 production |
Q36338729 | Type 2 diabetes - Tuberculosis co-morbidity is associated with diminished circulating levels of IL-20 subfamily of cytokines |
Q36765812 | Type 3 Muscarinic Receptors Contribute to Clearance of Citrobacter rodentium |
Q40185624 | Type 3 innate lymphoid cell-derived lymphotoxin prevents microbiota-dependent inflammation |
Q35762894 | Unexpected Role for Adaptive αβTh17 Cells in Acute Respiratory Distress Syndrome |
Q36180686 | Unique and redundant functions of NKp46+ ILC3s in models of intestinal inflammation |
Q41416579 | Up-regulated Reg proteins induced by Interleukin-22 treatment ameliorate acute liver injury in rat model |
Q38218882 | Update on innate lymphoid cells in atopic and non-atopic inflammation in the airways and skin |
Q30409296 | Viral infection of the lung: host response and sequelae |
Q35557138 | Virus infection stages and distinct Th1 or Th17/Th22 T-cell responses in malaria/SHIV coinfection correlate with different outcomes of disease |
Q91988091 | Vitamin A and vitamin D regulate the microbial complexity, barrier function, and the mucosal immune responses to ensure intestinal homeostasis |
Q61811649 | Vitamin D Is Required for ILC3 Derived IL-22 and Protection From Infection |
Q91610516 | Vitamin D/Vitamin D Receptor Signaling Is Required for Normal Development and Function of Group 3 Innate Lymphoid Cells in the Gut |
Q38003092 | What's the next best cytokine target in IBD? |
Q37486151 | Xenobiotic Receptor-Mediated Regulation of Intestinal Barrier Function and Innate Immunity |
Q34045124 | Yersinia enterocolitica promotes robust mucosal inflammatory T-cell immunity in murine neonates |
Q41348746 | Zbtb1 controls NKp46+ ROR-gamma-T+ innate lymphoid cell (ILC3) development |
Q35841384 | Zinc sequestration by the neutrophil protein calprotectin enhances Salmonella growth in the inflamed gut. |
Q86572699 | [Interleukin-22 - friend or foe?] |
Q89625928 | c-Maf restrains T-bet-driven programming of CCR6-negative group 3 innate lymphoid cells |
Q60956504 | is a microRNA safeguard for -induced inflammatory colon oncogenesis |
Q36302839 | rIL-22 as an adjuvant enhances the immunogenicity of rGroEL in mice and its protective efficacy against S. Typhi and S. Typhimurium |
Q100560002 | γδ T cells in tissue physiology and surveillance |
Q34161552 | γδ T cells protect against lung fibrosis via IL-22. |
Q38718920 | γδT Cells and Related Diseases |
Search more.